7Baggers
Quarterly
Annual
    Unit: USD2025-09-28 2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2022-10-02 2022-07-03 2022-04-03 2022-01-01 2021-10-03 2021-07-04 2021-04-04 2021-01-02 2020-09-27 2020-06-28 2020-03-29 2019-12-29 2019-09-29 2018-12-30 2018-09-30 2018-07-01 2018-04-01 2017-12-31 2017-10-01 2017-07-02 2017-04-02 2016-10-02 2016-07-03 2016-04-03 2016-01-01 2015-09-27 2015-06-28 2015-03-29 2015-01-03 2014-09-28 2014-06-29 2014-03-30 2013-09-29 2013-06-30 2013-03-31 2012-09-30 2012-07-01 2012-04-01 2011-10-02 2010-10-03 2009-09-27 
      
    		                                                    
      cash flows from operating activities
    		                                                    
      net earnings
    		5,152,000,000 5,537,000,000 10,999,000,000 3,431,000,000 2,694,000,000   4,049,000,000 26,028,000,000   4,458,000,000 4,814,000,000 5,149,000,000 1,799,000,000 3,667,000,000 6,278,000,000 6,197,000,000 7,902,000,000 3,554,000,000 3,626,000,000 5,796,000,000 4,010,000,000 1,753,000,000 3,042,000,000 3,934,000,000 3,954,000,000 4,367,000,000 -10,713,000,000 3,764,000,000 3,827,000,000 4,422,000,000 4,272,000,000 4,162,000,000 4,292,000,000 4,346,000,000 3,358,000,000 4,516,000,000 4,320,000,000 1,607,000,000 4,749,000,000 4,326,000,000 4,727,000,000 2,982,000,000 3,833,000,000 3,497,000,000 2,629,000,000 1,408,000,000 3,910,000,000 3,202,000,000 3,417,000,000 3,345,000,000 
      adjustments to reconcile net earnings to cash flows from operating activities:
    		                                                    
      depreciation and amortization of property and intangibles
    		1,777,000,000 1,943,000,000 1,772,000,000 1,896,000,000 1,846,000,000 1,782,000,000 1,815,000,000 1,843,000,000 1,829,000,000 1,934,000,000 1,880,000,000 1,685,000,000 1,744,000,000 1,769,000,000 1,423,000,000 1,814,000,000 1,839,000,000 1,894,000,000 2,099,000,000 1,818,000,000 1,726,000,000 1,747,000,000 1,816,000,000 1,727,000,000 1,735,000,000 1,731,000,000 1,717,000,000 1,746,000,000 1,869,000,000 1,711,000,000 1,150,000,000 912,000,000 908,000,000 900,000,000 891,000,000 1,041,000,000 929,000,000 889,000,000 895,000,000 842,000,000 939,000,000 952,000,000 1,013,000,000 976,000,000 990,000,000 1,036,000,000 1,005,000,000 852,000,000 773,000,000 783,000,000 725,000,000 675,000,000 
      stock based compensation
    		347,000,000 410,000,000 288,000,000 238,000,000 295,000,000 341,000,000 302,000,000 178,000,000 296,000,000 382,000,000 306,000,000 281,000,000 366,000,000 278,000,000 218,000,000 259,000,000 354,000,000 307,000,000 290,000,000 256,000,000 326,000,000 263,000,000 160,000,000 245,000,000 156,000,000 242,000,000 312,000,000 268,000,000 204,000,000 236,000,000 293,000,000 229,000,000 225,000,000 274,000,000 205,000,000 201,000,000 203,000,000 270,000,000 204,000,000 228,000,000 206,000,000 242,000,000 198,000,000 161,000,000 229,000,000 194,000,000 146,000,000 196,000,000 173,000,000 145,000,000 169,000,000 158,000,000 
      asset write-downs
    		93,000,000 0 30,000,000 26,000,000 0 194,000,000 185,000,000 475,000,000 432,000,000 -38,000,000 426,000,000 40,000,000 137,000,000 610,000,000 252,000,000 938,000,000 12,000,000 14,000,000 791,000,000 165,000,000 22,000,000 11,000,000 77,000,000 30,000,000 32,000,000 1,199,000,000   486,000,000 39,000,000 233,000,000 37,000,000 0 105,000,000 82,000,000 -84,000,000 356,000,000   365,000,000 87,000,000 135,000,000 37,000,000 178,000,000 0 69,000,000       
      charges for acquired in-process research and development assets
    		                                                    
      net gain on sale of assets/businesses
    		-57,000,000 1,000,000 -75,000,000 -1,000,000 -2,000,000   0 -70,000,000 -39,000,000 -8,000,000 0 -45,000,000 -168,000,000 221,000,000 0 -21,000,000 -580,000,000 -557,000,000 0    -46,000,000  0   -780,000,000 -474,000,000   -91,000,000   711,000,000 -240,000,000 -996,000,000 -38,000,000 -247,000,000 -2,004,000,000            
      deferred tax provision
    		2,218,000,000 825,000,000 2,172,000,000 -16,000,000 90,000,000 -695,000,000 -1,562,000,000 -2,412,000,000 560,000,000 -799,000,000 -1,543,000,000 -139,000,000 -1,423,000,000 -926,000,000 901,000,000 -1,879,000,000 45,000,000 -730,000,000 -1,841,000,000 190,000,000 -482,000,000 54,000,000 -350,000,000 -1,432,000,000 -1,069,000,000 338,000,000 -329,000,000 44,000,000 2,813,000,000 -335,000,000 -45,000,000 -27,000,000 100,000,000 -278,000,000 393,000,000 -574,000,000 -51,000,000 -261,000,000 545,000,000 -567,000,000 -296,000,000 98,000,000 495,000,000 -316,000,000 -273,000,000 365,000,000 187,000,000 -1,068,000,000 557,000,000 -345,000,000   
      credit losses and accounts receivable allowances
    		-9,000,000 7,000,000 -4,000,000 22,000,000       1,000,000 -11,000,000 -9,000,000 6,000,000 43,000,000 -8,000,000 -39,000,000 -13,000,000 -122,000,000 -43,000,000                                 
      changes in assets and liabilities, net of effects from acquisitions and divestitures:
    		                                                    
      increase in accounts receivable
    		111,000,000 -1,357,000,000 -926,000,000 853,000,000 -96,000,000 -884,000,000 -279,000,000 227,000,000 -252,000,000 -545,000,000 -54,000,000 -205,000,000 -959,000,000 -427,000,000  -252,000,000 38,000,000 -1,604,000,000  80,000,000   376,000,000 -329,000,000 -145,000,000 -51,000,000 -510,000,000 -479,000,000 -333,000,000 176,000,000 -380,000,000 -96,000,000 362,000,000 -709,000,000 -389,000,000 -155,000,000 276,000,000 -421,000,000 -765,000,000 -34,000,000 185,000,000 -158,000,000 -426,000,000   -434,000,000   -215,000,000 87,000,000 -30,000,000 164,000,000 
      increase in inventories
    		-748,000,000 -510,000,000 -146,000,000 -90,000,000 -299,000,000 -391,000,000 -348,000,000 124,000,000 -706,000,000 -217,000,000 -524,000,000 -620,000,000 -657,000,000 -600,000,000 -1,349,000,000 -360,000,000 -123,000,000 -695,000,000 -464,000,000 -147,000,000 -478,000,000 -159,000,000  -1,000,000  -286,000,000 -169,000,000 -322,000,000  228,000,000 -53,000,000 -368,000,000 35,000,000 -253,000,000 -190,000,000 470,000,000 -182,000,000 -261,000,000 -276,000,000 649,000,000 -493,000,000 -93,000,000 -512,000,000 -252,000,000 -259,000,000 -288,000,000 25,000,000 -169,000,000 -449,000,000 -167,000,000 -109,000,000 89,000,000 
      increase in accounts payable and accrued liabilities
    		   -1,092,000,000    1,682,000,000               1,787,000,000  3,220,000,000    2,386,000,000                        
      (increase)/decrease in other current and non-current assets
    		-1,459,000,000 -4,877,000,000 -1,317,000,000     -2,114,000,000 -222,000,000 -229,000,000 -915,000,000                      251,000,000                    
      decrease in other current and non-current liabilities
    		-270,000,000 583,000,000 -6,509,000,000         -1,552,000,000     -248,000,000 -902,000,000   -500,000,000 -329,000,000                     -428,000,000          
      net cash flows from operating activities
    		9,169,000,000 3,878,000,000 4,174,000,000 6,983,000,000 7,993,000,000 5,633,000,000 3,657,000,000 7,863,000,000 7,489,000,000 4,182,000,000 3,257,000,000 6,284,000,000 5,581,000,000 3,979,000,000 3,516,000,000 8,290,000,000 5,314,000,000 4,074,000,000 8,217,000,000 8,383,000,000 3,452,000,000 3,358,000,000 6,398,000,000 7,527,000,000 6,244,000,000 6,272,000,000 6,079,000,000 3,606,000,000 6,105,000,000 6,266,000,000 5,772,000,000 2,913,000,000 5,361,000,000 4,990,000,000 1,763,000,000 4,570,000,000 6,125,000,000 5,200,000,000 2,872,000,000 5,173,000,000 4,654,000,000 5,529,000,000 3,923,000,000 5,947,000,000 5,051,000,000 2,277,000,000 4,497,000,000 4,728,000,000 2,795,000,000 4,622,000,000 5,034,000,000 5,094,000,000 
      cash flows from investing activities
    		                                                    
      additions to property, plant and equipment
    		-1,157,000,000 -1,043,000,000 -795,000,000 -1,612,000,000 -1,029,000,000 -976,000,000 -807,000,000 -1,589,000,000 -967,000,000 -1,124,000,000 -863,000,000 -952,000,000 -863,000,000 -607,000,000 -1,772,000,000 -747,000,000 -813,000,000 -677,000,000 -1,628,000,000 -737,000,000 -662,000,000 -625,000,000 -1,260,000,000 -745,000,000 -1,318,000,000 -819,000,000 -875,000,000 -658,000,000 -1,240,000,000 -790,000,000 -689,000,000 -560,000,000 -737,000,000 -757,000,000 -639,000,000 -1,129,000,000 -789,000,000 -765,000,000 -543,000,000 -1,245,000,000 -751,000,000 -837,000,000 -630,000,000 -809,000,000 -771,000,000 -586,000,000 -682,000,000 -598,000,000 -502,000,000 -711,000,000 -528,000,000 -519,000,000 
      proceeds from the disposal of assets/businesses
    		76,000,000 53,000,000 279,000,000 52,000,000 50,000,000 363,000,000 210,000,000 121,000,000 121,000,000 76,000,000 40,000,000 8,000,000 66,000,000 248,000,000 -123,000,000 12,000,000 51,000,000 603,000,000 611,000,000 13,000,000 70,000,000 17,000,000 162,000,000 85,000,000 2,308,000,000 25,000,000 850,000,000 20,000,000 1,106,000,000 601,000,000 94,000,000 31,000,000 188,000,000 660,000,000 25,000,000 -353,000,000 427,000,000 1,083,000,000 110,000,000 -1,017,000,000 3,908,000,000            
      acquisitions, net of cash acquired
    		-1,000,000   -1,000,000 -338,000,000 -12,996,000,000 -1,811,000,000     1,000,000 -271,000,000 -252,000,000     889,000,000 0 -10,000,000 -939,000,000 -248,000,000 -216,000,000 -2,000,000 -675,000,000 -140,000,000 -82,000,000 -505,000,000 -574,000,000 -29,220,000,000 -4,852,000,000 -3,320,000,000 -725,000,000 -5,000,000 -4,276,000,000 0 0 -233,000,000 -663,000,000    -645,000,000 -6,000,000 -168,000,000 13,236,000,000   -420,000,000 -398,000,000 -1,046,000,000 
      acquired in-process research and development assets / related milestones
    		-16,000,000                                                    
      purchases of investments
    		-246,000,000 -180,000,000 -251,000,000 -262,000,000 -280,000,000 -554,000,000 -630,000,000 -925,000,000 -293,000,000 -5,914,000,000 -3,774,000,000 -9,115,000,000 -13,030,000,000 -9,018,000,000 -13,541,000,000 -6,579,000,000 -6,270,000,000 -5,994,000,000 -14,151,000,000 -7,692,000,000 -6,487,000,000 -2,064,000,000 -1,236,000,000 -1,167,000,000 -1,471,000,000 -3,204,000,000 -403,000,000 -548,000,000 -355,000,000 -571,000,000 -677,000,000 -4,550,000,000 -10,166,000,000 -7,449,000,000 -10,062,000,000 -5,184,000,000 -7,953,000,000 -13,651,000,000 -7,162,000,000 -15,044,000,000 -8,432,000,000 -11,925,000,000 -5,427,000,000 -5,014,000,000 -5,018,000,000 -3,551,000,000 -3,626,000,000 -2,813,000,000 -2,398,000,000 -8,624,000,000 -3,984,000,000 -2,437,000,000 
      sales of investments
    		489,000,000 735,000,000 218,000,000 290,000,000 466,000,000 727,000,000 979,000,000 3,603,000,000 3,910,000,000 4,111,000,000 7,766,000,000 8,690,000,000 11,331,000,000 6,303,000,000 24,800,000,000 4,356,000,000 7,220,000,000 5,233,000,000 18,421,000,000 4,168,000,000 873,000,000 1,544,000,000 928,000,000 327,000,000 3,127,000,000 419,000,000 402,000,000 341,000,000 606,000,000 191,000,000 18,326,000,000 8,994,000,000 11,662,000,000 9,630,000,000 9,145,000,000 12,613,000,000 7,338,000,000 9,779,000,000 6,050,000,000 19,573,000,000 6,354,000,000 4,145,000,000 4,077,000,000 4,894,000,000 5,197,000,000 2,800,000,000 2,251,000,000 3,283,000,000 6,600,000,000 7,856,000,000 2,869,000,000 2,226,000,000 
      credit support agreements activity
    		346,000,000 -2,980,000,000 296,000,000 818,000,000 -731,000,000 -170,000,000 1,600,000,000 -2,046,000,000 -119,000,000 -956,000,000 158,000,000 -295,000,000 239,000,000 -249,000,000 -945,000,000 255,000,000 -310,000,000 751,000,000                                   
      other
    		-33,000,000 -36,000,000 -30,000,000 -72,000,000 -16,000,000 -81,000,000 -5,000,000 104,000,000 -111,000,000 31,000,000 -12,000,000 -38,000,000 -111,000,000 -59,000,000 185,000,000 -16,000,000 -297,000,000 -101,000,000 8,000,000 -24,000,000 -235,000,000 -257,000,000 -28,000,000 71,000,000 -416,000,000 -15,000,000 -35,000,000 2,000,000 -117,000,000 -37,000,000 -81,000,000 1,000,000 1,000,000 -37,000,000 -1,000,000 -88,000,000 -24,000,000 0 -11,000,000 44,000,000 -53,000,000 -13,000,000 -81,000,000 -24,000,000 -12,000,000 -4,000,000 4,000,000 -6,000,000 -2,000,000 -269,000,000 -49,000,000 -79,000,000 
      net cash from investing activities
    		                                                    
      cash flows from financing activities
    		                                                    
      dividends to shareholders
    		-3,132,000,000 -3,129,000,000 -2,989,000,000 -2,984,000,000 -2,985,000,000 -2,985,000,000 -2,869,000,000 -2,865,000,000 -2,871,000,000 -3,092,000,000 -2,942,000,000 -2,970,000,000 -2,971,000,000 -2,787,000,000 -3,441,000,000 -2,791,000,000 -2,791,000,000 -2,659,000,000 -3,209,000,000 -2,659,000,000 -2,659,000,000 -2,505,000,000 -2,500,000,000 -2,499,000,000 -2,411,000,000 -2,415,000,000 -2,415,000,000 -2,253,000,000 -2,256,000,000 -2,254,000,000 -2,262,000,000 -2,171,000,000 -2,185,000,000 -2,197,000,000 -2,069,000,000 -2,520,000,000 -2,076,000,000 -2,079,000,000 -1,946,000,000 -2,361,000,000 -1,967,000,000 -1,978,000,000 -1,867,000,000 -1,862,000,000 -1,856,000,000 -1,706,000,000 -1,683,000,000 -1,676,000,000 -1,565,000,000 -1,558,000,000 -1,484,000,000 -1,351,000,000 
      repurchase of common stock
    		-1,902,000,000 0 -2,127,000,000 -282,000,000 -539,000,000 -136,000,000 -1,475,000,000 -216,000,000 -920,000,000 -381,000,000 -3,537,000,000 -2,165,000,000 -973,000,000 -1,577,000,000 -3,575,000,000 -391,000,000 -631,000,000 -1,438,000,000 -556,000,000 -483,000,000 -706,000,000 -1,711,000,000 -426,000,000 -1,628,000,000 -3,808,000,000 -471,000,000 -145,000,000 -1,444,000,000 -815,000,000 -311,000,000 -1,890,000,000 -3,342,000,000 -2,203,000,000 -2,362,000,000 -2,389,000,000 -5,585,000,000 -300,000,000 -896,000,000 -2,198,000,000 -909,000,000 -2,415,000,000 -1,192,000,000 -774,000,000    0 -12,852,000,000 -67,000,000 -743,000,000 -732,000,000 -49,000,000 
      proceeds from short-term debt
    		1,324,000,000 565,000,000 8,784,000,000 3,293,000,000 -1,992,000,000 8,713,000,000 5,263,000,000 1,281,000,000 241,000,000 1,127,000,000 11,094,000,000 2,728,000,000 1,352,000,000 3,019,000,000 14,851,000,000 785,000,000 475,000,000 23,000,000 -1,338,000,000 618,000,000 2,707,000,000 10,000,000 -109,000,000 133,000,000 40,000,000 13,000,000 1,000,000 26,000,000 -3,891,000,000 2,125,000,000 1,916,000,000 719,000,000 31,000,000 23,000,000 95,000,000 -1,996,000,000 1,083,000,000 435,000,000 589,000,000 1,787,000,000 -1,039,000,000 1,390,000,000 278,000,000 88,000,000 1,207,000,000 475,000,000 1,088,000,000 971,000,000 1,547,000,000 3,630,000,000 940,000,000 821,000,000 
      repayment of short-term debt
    		-5,466,000,000 -2,938,000,000 -2,120,000,000 -1,109,000,000 -4,439,000,000 -3,025,000,000 -890,000,000 -1,328,000,000 -8,034,000,000 -8,223,000,000 -5,388,000,000 -2,607,000,000 -1,345,000,000 -856,000,000 -5,729,000,000 -132,000,000 -214,000,000 -475,000,000 -880,000,000 -293,000,000 1,000,000 -18,000,000                               
      proceeds from long-term debt, net of issuance costs
    		0 0 9,138,000,000 0 1,000,000 6,657,000,000 2,000,000   0 7,674,000,000 -1,000,000   -1,000,000 2,000,000 0 1,000,000 -7,426,000,000 7,430,000,000   2,000,000 0 -1,000,000 3,000,000 1,000,000 2,000,000 4,527,000,000 1,000,000 0 4,464,000,000 0 4,516,000,000 7,435,000,000                  
      repayment of long-term debt
    		-1,001,000,000 -3,000,000 -751,000,000 -649,000,000 -1,000,000 -802,000,000 -1,000,000 -1,049,000,000 -1,000,000 -1,000,000 -500,000,000 -1,000,000 0 -2,132,000,000 -682,000,000 -1,000,000 -450,000,000 -1,001,000,000 -1,240,000,000 -551,000,000 0 -11,000,000                               
      proceeds from the exercise of stock options/employee withholding tax on stock awards
    		1,274,000,000 107,000,000 450,000,000 124,000,000 424,000,000 95,000,000 195,000,000 187,000,000 653,000,000 265,000,000 -11,000,000 87,000,000 499,000,000 321,000,000 521,000,000 265,000,000 307,000,000 236,000,000 114,000,000 214,000,000 376,000,000 332,000,000 374,000,000 117,000,000 469,000,000 318,000,000 96,000,000 66,000,000 208,000,000 135,000,000 317,000,000 402,000,000 183,000,000                    
      settlement of convertible debt acquired from shockwave
    		    0                                                
      net cash from financing activities
    		-8,927,000,000 -5,665,000,000 10,422,000,000                                                  
      effect of exchange rate changes on cash and cash equivalents
    		-46,000,000        -168,000,000 -97,000,000 28,000,000 -286,000,000 -161,000,000 16,000,000 -187,000,000 -92,000,000 45,000,000 -78,000,000 -43,000,000 31,000,000 71,000,000 -237,000,000 74,000,000 -116,000,000 -32,000,000 -39,000,000 -274,000,000 104,000,000 40,000,000 106,000,000 81,000,000 110,000,000 21,000,000 -69,000,000 81,000,000 967,000,000 -299,000,000 -492,000,000 -391,000,000 -1,298,000,000 -91,000,000 -55,000,000 -45,000,000 22,000,000 -53,000,000 -153,000,000 54,000,000 -89,000,000 57,000,000 -157,000,000 165,000,000 173,000,000 
      decrease in cash and cash equivalents
    		             -4,024,000,000    -1,314,000,000   -4,356,000,000 -1,775,000,000  1,873,000,000  -1,513,000,000           3,000,000,000 -1,349,000,000 -2,535,000,000    -1,205,000,000    1,444,000,000   643,000,000   
      cash and cash equivalents, beginning of period
    		0           0 0 14,487,000,000  0 0 13,985,000,000  0 0 17,305,000,000  0  0 0 17,824,000,000  0 0 18,972,000,000 0 0 13,732,000,000  0 0 14,523,000,000  0 0 20,927,000,000 0 0 14,911,000,000 0 0 24,542,000,000 0 0 0 
      cash and cash equivalents, end of period
    		-346,000,000        -1,455,000,000   372,000,000 520,000,000 10,463,000,000  3,272,000,000 1,661,000,000 12,671,000,000  7,791,000,000 -4,356,000,000 15,530,000,000  1,873,000,000  -1,513,000,000 2,930,000,000 14,639,000,000  3,123,000,000 -8,311,000,000 20,909,000,000 -435,000,000 4,779,000,000 13,861,000,000  3,000,000,000 -1,349,000,000 11,988,000,000  -418,000,000 -5,486,000,000 19,722,000,000 -103,000,000 2,452,000,000 14,855,000,000 1,444,000,000 -16,225,000,000 30,267,000,000 643,000,000 1,625,000,000 170,000,000 
      charges for purchase of in-process research and development assets
    		 76,000,000 16,000,000                                                  
      (decrease) / increase in accounts payable and accrued liabilities
    		                                                    
      net cash used by investing activities
    		 -18,264,000,000 -297,000,000         -1,701,000,000 -2,639,000,000 -3,634,000,000 -9,048,000,000 -2,719,000,000 -419,000,000 -185,000,000 4,239,000,000 -4,819,000,000 -7,522,000,000 -581,000,000 -1,344,000,000 -1,645,000,000 2,228,000,000 -4,269,000,000 -201,000,000 -925,000,000 -505,000,000 -1,180,000,000 -12,247,000,000 -936,000,000 -2,372,000,000 1,322,000,000 -1,537,000,000 1,583,000,000 -1,001,000,000 -3,554,000,000 -1,789,000,000 1,648,000,000 735,000,000 -8,092,000,000 -2,026,000,000 -1,553,000,000   11,398,000,000   -1,590,000,000 -1,875,000,000 -1,855,000,000 
      (decrease) / increase in cash and cash equivalents
    		                                                    
      decrease in accounts payable and accrued liabilities
    		  -2,126,000,000    -2,483,000,000   1,511,000,000 -2,572,000,000  1,647,000,000 -2,817,000,000   -1,714,000,000 -2,336,000,000   204,000,000 -2,523,000,000     1,637,000,000 -1,686,000,000   829,000,000 -2,030,000,000 -173,000,000 1,286,000,000 -2,333,000,000  645,000,000 248,000,000 -2,451,000,000   409,000,000 -1,004,000,000   -1,459,000,000   -1,331,000,000 344,000,000 167,000,000 67,000,000 
      acquired in-process research and development assets
    		  -14,000,000                                                  
      form 10-q
    		                                                    
      gain on kenvue separation
    		       0                                             
      decrease/(increase) in other current and non-current assets
    		   768,000,000 -2,782,000,000 532,000,000 3,199,000,000        -1,395,000,000 667,000,000                        -7,000,000             
      increase/(decrease) in other current and non-current liabilities
    		       3,328,000,000 -1,147,000,000     110,000,000                 -98,000,000 420,000,000      15,000,000 1,021,000,000     1,186,000,000         
      net cash (used by)/from investing activities
    		                                             -1,403,000,000       
      48
    		                                                    
      charge for purchase of in-process research and development assets
    		                                                    
      (decrease)/increase in other current and non-current liabilities
    		    2,742,000,000 -2,641,000,000 -427,000,000        -41,000,000                  -522,000,000 -481,000,000 -385,000,000           -192,000,000 -15,000,000      
      purchases of in-process research and development assets
    		                                                    
      net cash (used by) / from investing activities
    		                                                    
      proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to kenvue at separation
    		                                                    
      proceeds from kenvue initial public offering
    		        0                                            
      cash transferred to kenvue at separation
    		                                                    
      increase/(decrease) in accounts payable and accrued liabilities
    		                                              321,000,000      
      net cash flows from financing activities
    		     7,544,000,000 546,000,000                                              
      net earnings/
    		      3,255,000,000                                              
      net cash (used by)/ from investing activities
    		      -464,000,000                                              
      net cash from/(used) by investing activities
    		                                                    
      net cash from (used by) investing activities
    		                                                    
      net cash used by financing activities
    		           -3,925,000,000 -2,261,000,000 -4,385,000,000 1,740,000,000 -2,207,000,000 -3,279,000,000 -5,125,000,000 -13,571,000,000 4,196,000,000 -357,000,000 -4,315,000,000 -4,072,000,000 -3,893,000,000 -6,389,000,000 -3,477,000,000 -2,674,000,000 -5,970,000,000 -3,537,000,000 -2,069,000,000 -1,917,000,000 -150,000,000 -3,445,000,000 -1,464,000,000 -178,000,000 -996,000,000 -1,825,000,000 -2,503,000,000 -3,227,000,000 795,000,000 -5,716,000,000 -2,868,000,000 -3,057,000,000 -4,519,000,000 -1,977,000,000 -777,000,000 -14,505,000,000 -3,403,000,000 -1,183,000,000 -2,232,000,000 -1,699,000,000 -3,242,000,000 
      increase/(decrease) in cash and cash equivalents
    		        -1,455,000,000          -1,158,000,000              -435,000,000 4,779,000,000 129,000,000         -103,000,000         
      cash and cash equivalents from continuing operations, beginning of period
    		                                                    
      cash and cash equivalents from discontinued operations, beginning of period
    		                                                    
      cash and cash equivalents beginning of period
    		        0 0 14,127,000,000                                          
      cash and cash equivalents from continuing operations, end of period
    		                                                    
      cash and cash equivalents from discontinued operations, end of period
    		                                                    
      acquisitions
    		                                                    
      fair value of assets acquired
    		           -1,000,000 366,000,000 255,000,000      0 37,000,000 1,136,000,000  117,000,000  712,000,000 215,000,000 119,000,000  333,000,000 30,911,000,000 5,250,000,000 3,350,000,000 737,000,000 7,000,000  0 1,000,000 476,000,000     820,000,000 6,000,000 186,000,000    441,000,000 412,000,000 1,674,000,000 
      fair value of liabilities assumed
    		                                                    
      net cash paid for acquisitions
    		           -1,000,000 271,000,000 252,000,000      0 10,000,000 939,000,000  216,000,000  675,000,000 140,000,000 82,000,000  574,000,000 29,220,000,000 4,852,000,000 3,320,000,000 725,000,000 5,000,000         645,000,000      420,000,000 398,000,000 1,046,000,000 
      net cash from/(used by) financing activities
    		         -5,991,000,000 6,138,000,000                                          
      net (loss)/earnings
    		          -68,000,000                                          
      increase in other current and non-current liabilities
    		          6,328,000,000                 595,000,000                     89,000,000 547,000,000   
      net cash from/(used by) investing activities
    		          3,315,000,000                                          
      increase/(decrease) in cash, cash equivalents and restricted cash
    		          12,738,000,000                                          
      cash, cash equivalents and restricted cash, end of period
    		          26,865,000,000                                          
      decrease in other current and non-current assets
    		           1,036,000,000 2,532,000,000 995,000,000    2,522,000,000                  -968,000,000                 
      (decrease)/increase in cash and cash equivalents
    		           372,000,000                -3,185,000,000 2,103,000,000 3,123,000,000          6,318,000,000 -418,000,000     -56,000,000     1,625,000,000  
      fair value of liabilities assumed and noncontrolling interests
    		           0 -95,000,000 -3,000,000      0 -27,000,000 -197,000,000  99,000,000  -37,000,000 -75,000,000 -37,000,000  241,000,000 -1,691,000,000 -398,000,000 -30,000,000 -12,000,000 -2,000,000  0 -1,000,000 -243,000,000     -175,000,000 0 -18,000,000       
      contingent consideration reversal
    		                   -165,000,000 0 -983,000,000                               
      (increase)/decrease in accounts receivable
    		                                           -324,000,000         
      cash and cash equivalents, beginning of year
    		                                                    
      cash and cash equivalents, end of year
    		                                                    
      supplemental cash flow data
    		                                                    
      cash paid during the year for:
    		                                                    
      interest
    		                                                    
      interest, net of amount capitalized
    		                                                    
      income taxes
    		                                                    
      increase in cash and cash equivalents
    		                               1,937,000,000                 5,725,000,000   170,000,000 
      increase in other current and non-current assets
    		                  19,000,000 -935,000,000   -973,000,000 781,000,000 629,000,000 -637,000,000 640,000,000 -907,000,000 144,000,000 -14,000,000 32,000,000 -573,000,000   -802,000,000    -562,000,000   -412,000,000 -152,000,000 34,000,000 171,000,000 -608,000,000 -761,000,000 725,000,000 -754,000,000 14,000,000 394,000,000 -7,000,000 
      (decrease)/increase in accounts payable and accrued liabilities
    		                                       824,000,000             
      proceeds from credit support agreements
    		                   -547,000,000 -1,071,000,000 1,743,000,000                               
      accounts receivable allowances and credit losses
    		                     22,000,000                               
      (increase) / decrease in accounts receivable
    		                     -812,000,000                               
      decrease / (increase) in other current and non-current assets
    		                     271,000,000                               
      decrease/(increase) in accounts receivable
    		                                              -61,000,000      
      gain on sale of assets/businesses
    		                                                    
      accounts receivable allowances
    		                      -5,000,000 -16,000,000 -28,000,000 13,000,000 4,000,000 -20,000,000 -42,000,000 35,000,000 37,000,000 -13,000,000 -6,000,000 -3,000,000 -1,000,000 -13,000,000 -3,000,000 26,000,000 -21,000,000 72,000,000 -17,000,000 -12,000,000 -25,000,000 -3,000,000 -18,000,000 -11,000,000 3,000,000 41,000,000 42,000,000 12,000,000 -16,000,000 -13,000,000 
      (increase)/decrease in inventories
    		                                                    
      increase / (decrease) in other current and non-current liabilities
    		                                                    
      retirement of short-term debt
    		                       -75,000,000 -114,000,000 68,000,000 51,000,000 -2,484,000,000 -394,000,000 -756,000,000 15,000,000 -195,000,000 761,000,000 -515,000,000 -4,172,000,000 -1,087,000,000 -585,000,000 -152,000,000 -193,000,000 669,000,000 -647,000,000 209,000,000 -1,275,000,000 -142,000,000 -570,000,000 -704,000,000 -1,000,000,000 -2,990,000,000 -1,790,000,000 -3,850,000,000 -1,792,000,000 -2,681,000,000 
      retirement of long-term debt
    		                       -3,000,000 -645,000,000 -901,000,000 -1,000,000 -8,000,000 -753,000,000 -1,009,000,000 -13,000,000 -2,000,000 -17,000,000 -922,000,000 -14,000,000 -2,196,000,000 -6,000,000 -5,000,000 -16,000,000 1,719,000,000 -10,000,000 -1,756,000,000 -21,000,000 -27,000,000 -1,503,000,000 -1,000,000 -786,000,000 20,000,000 -30,000,000 -7,000,000 -9,000,000 -208,000,000 
      net gain on sale of assets
    		                                                    
      venezuela adjustments
    		                                       33,000,000 26,000,000            
      decrease/(increase) in inventories
    		                                                    
      proceeds from the exercise of stock options/excess tax benefits
    		                                  936,000,000  59,000,000 194,000,000 584,000,000 -111,000,000 358,000,000 462,000,000 586,000,000 429,000,000 719,000,000 1,123,000,000 669,000,000 268,000,000 880,000,000 229,000,000 299,000,000 226,000,000 
      proceeds from long-term debt
    		                                   12,001,000,000 0 0 3,000,000 58,000,000 4,000,000 -3,000,000 16,000,000 45,000,000 0 6,000,000 10,000,000 4,000,000 2,000,000 67,000,000  0 
      changes in assets and liabilities, net of effects from acquisitions:
    		                                                    
      net fair value of acquisitions
    		                                    0 0 233,000,000     645,000,000 6,000,000 168,000,000       
      net gain on equity investment transactions
    		                                           21,000,000         
      raw materials and supplies
    		                                        -86,000,000            
      goods in process
    		                                        167,000,000            
      finished goods
    		                                        183,000,000            
      total inventories
    		                                        264,000,000            
      venezuela currency devaluation
    		                                           0 0 108,000,000       
      proceeds from the disposal of assets
    		                                          35,000,000 45,000,000 41,000,000 106,000,000 215,000,000 332,000,000 358,000,000 578,000,000 215,000,000 0 
      noncontrolling interest
    		                                                    
      johnson & johnson and subsidiariesconsolidated statements of cash flows
    		                                                    
      supplemental schedule of non-cash investing and financing activities
    		                                                    
      issuance of common stock associated with the acquisition of synthes, inc.
    		                                                    
      less: issuance of common stock associated with the acquisition of synthes, inc.
    		                                                    
      intangible asset write-downs
    		                                              679,000,000      
      reissuance of common stock
    		                                                    
      fair value of liabilities assumed and non-controlling interests
    		                                                 -21,000,000   
      cash flow from operating activities
    		                                                    
      net cash flows from investing activities
    		                                                4,056,000,000    
      decrease in deferred tax provision
    		                                                  40,000,000  
      net cash(used by)/from financing activities
    		                                                    
      purchased in-process research and development
    		                                                    
      decrease/(increase) in deferred tax provision
    		                                                   -104,000,000 
      adjustment to reconcile net earnings to cash flows from operating activities:
    		                                                    
      adjustments to reconcile net earnings to cash flow:
    		                                                    
      net cash provided/(used) by investing activities
    		                                                    
      proceeds from the exercise of stock options and related excess tax benefits
    		                                                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.